OPTHNASDAQBasic Materials· Agricultural Inputs

Optimi Health Corp.

$6.08+10.55%(+$0.58)
TickerSpark Score

Not enough financial coverage to compute a composite score for OPTH. This is typical for foreign-listed ADRs, recent IPOs, or thinly-covered small caps. Live quote, chart, and any available data still render below.

Momentum30
52-Week Range73% of range
Low $5.20
Current $6.08
High $6.40

Companywww.optimihealth.ca

Optimi Health Corp. functions as an end-to-end GMP manufacturer and supplier of psychedelic substances. It offers formulation, active pharmaceutical ingredients (APIs), and drug product manufacturing from preclinical stages to analysis and commercial distribution and It also offers botanical psilocybin and MDMA.

CEO
Dane Stevens
IPO
2026
Employees
10
HQ
Vancouver, CA

Performance & Tape

52W High
$6.40
52W Low
$5.20
50D MA
$6.08
200D MA
$6.08
Beta
0.00
Avg Volume
0

Get TickerSpark's AI analysis on OPTH

Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.

Get Pro Access →

30-day money-back guarantee · cancel anytime

Our OPTH Coverage

View all →
Optimi Health Corp. IPO: What to Know Before It Lists
ipo_article

Optimi Health Corp. IPO: What to Know Before It Lists

Optimi Health Corp. (NASDAQ: OPTH) is expected to list on 2026-05-20, with a price range not disclosed and 2,500,000 shares offered. The setup is a small, early commercial psychedelic manufacturer with real revenue, but it is still carrying losses, a working capital deficit, and heavy regulatory dependence.

May 20, 2026

Want a deeper read on OPTH?

Generate a full analyst-grade report — bull / bear case, price targets, valuation depth, and a complete financial breakdown.

Generate OPTH Report →